Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Psychemedics Corporation

Psychemedics Corporation (PMD) Stock Overview

Explore Psychemedics Corporation’s financial performance, market position, analyst ratings, and future outlook.

PMD●NASDAQ
HealthcareMedical - Diagnostics & Research
$2.67
$0.00(0.00%)
U.S. Market opens in 11h 44m

Psychemedics Corporation (PMD)

Meyka AI Score

Z

Key Financials

Market Cap15.6M
P/E Ratio-8.34
EPS (TTM)$-0.51
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Psychemedics Corporation (NASDAQ: PMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Psychemedics Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PMD on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Psychemedics Corporation's NASDAQ-traded stock include a P/E ratio of -8.34 and a market capitalization of 15.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PMD on the NASDAQ.

Price Performance (NASDAQ: PMD)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
20.81%
3-Year Change
-56.94%
5-Year Change
-62.66%
All-Time (Max) Change
-78.84%

Contact Information

https://www.psychemedics.com
978 206 8220
289 Great Road, Acton, MA, 01720

Company Facts

1,160 Employees
IPO DateJan 22, 1987
CountryUS

Frequently Asked Questions